Latest & greatest articles for hepatitis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hepatitis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hepatitis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hepatitis

81. Kushenin combined with entecavir or adefovir dipivoxil for chronic hepatitis B: a systematic review and meta-analysis

Kushenin combined with entecavir or adefovir dipivoxil for chronic hepatitis B: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

82. Acupuncture for chronic hepatitis B [Cochrane protocol]

Acupuncture for chronic hepatitis B [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

83. A systematic review of outcomes of patients with chronic hepatitis C vs. patients without chronic hepatic C undergoing total hip or total knee arthroplasty

A systematic review of outcomes of patients with chronic hepatitis C vs. patients without chronic hepatic C undergoing total hip or total knee arthroplasty Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

84. The prevalence of Hepatitis B in Pakistan: a systematic review and meta-analysis

The prevalence of Hepatitis B in Pakistan: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

85. Efficacy and safety of antiviral therapy during pregnancy for the prevention of mother-to-child transmission of Hepatitis B Virus: a systematic review and meta-analysis

Efficacy and safety of antiviral therapy during pregnancy for the prevention of mother-to-child transmission of Hepatitis B Virus: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

86. Interventions to increase testing, linkage to care and retention in and completion of treatment for hepatitis C virus

Interventions to increase testing, linkage to care and retention in and completion of treatment for hepatitis C virus Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

87. Sustained virologic response rates of sofosbuvir and velpatasvir in patients with genotype 3 hepatitis C - a meta-analysis

Sustained virologic response rates of sofosbuvir and velpatasvir in patients with genotype 3 hepatitis C - a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

88. Radix Sophorae flavescentis versus antiviral drugs for chronic hepatitis B [Cochrane protocol]

Radix Sophorae flavescentis versus antiviral drugs for chronic hepatitis B [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

89. Prevalence of hepatitis C virus amongst people who use performance- and image-enhancing drugs: a systematic review

Prevalence of hepatitis C virus amongst people who use performance- and image-enhancing drugs: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

90. Effectiveness of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B, a meta-analysis

Effectiveness of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B, a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

91. Association between hepatitis B virus infection and malaria a systematic review

Association between hepatitis B virus infection and malaria a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

92. A meta-analysis comparing the effects of entecavir, tenofovir and pegylated interferon alfa on the incidence of hepatocellular carcinoma in patients with chronic hepatitis B

A meta-analysis comparing the effects of entecavir, tenofovir and pegylated interferon alfa on the incidence of hepatocellular carcinoma in patients with chronic hepatitis B Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

93. Epidemiology of severe mental illness among hepatitis infection patients: a systematic review and meta-analysis of studies worldwide

Epidemiology of severe mental illness among hepatitis infection patients: a systematic review and meta-analysis of studies worldwide Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

94. Efficacy and safety of anti-viral therapy for Hepatitis B virus (HBV) infection-related glomerulonephritis : a meta-analysis

Efficacy and safety of anti-viral therapy for Hepatitis B virus (HBV) infection-related glomerulonephritis : a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

95. Impact of baseline resistance-associated substitutions on treatment response in patients with Hepatitis C virus infection receiving pan-genotypic directly acting antivirals

Impact of baseline resistance-associated substitutions on treatment response in patients with Hepatitis C virus infection receiving pan-genotypic directly acting antivirals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

96. Immunogenicity and safety of hepatitis B vaccine in infants who are preterm and/or have low birth weight: a meta-analysis

Immunogenicity and safety of hepatitis B vaccine in infants who are preterm and/or have low birth weight: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

97. Hepatic rupture in preeclampsia and HELLP Syndrome: review of a catastrophic presentation

Hepatic rupture in preeclampsia and HELLP Syndrome: review of a catastrophic presentation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

98. Birth cohort screening for hepatitis C: a systematic review of cost-effectiveness

Birth cohort screening for hepatitis C: a systematic review of cost-effectiveness Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

99. Dipeptidyl peptidase IV inhibitors for the treatment of non-alcoholic hepatic steatohepatitis

Dipeptidyl peptidase IV inhibitors for the treatment of non-alcoholic hepatic steatohepatitis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

100. Comparison of sequential, incremental and concomitant reintroduction regimens of anti-tubercular therapy after initial episode of anti-tubercular therapy induced hepatitis: a systematic review and network meta-analysis

Comparison of sequential, incremental and concomitant reintroduction regimens of anti-tubercular therapy after initial episode of anti-tubercular therapy induced hepatitis: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete

2019 PROSPERO